Why ‘Risky’ AI Medical Devices Are Launching In Market
A new study finds that publicly traded companies’ AI medical devices face more recalls and less clinical testing before market approval.
External Source
Read the full article or press release at the original source.
Visit Original SourceRelated Articles
Baird Medical Launches in Egyptian Market
Baird Medical launches in Egypt with the first bone ablation procedure using MWA system at Ain Shams Hospital.
Health groups urge passage of bill to ease Medicare pay cuts for tests
More than 30 organizations, including AdvaMed and the American Clinical Laboratory Association, are pushing for a permanent legislative solution to…
Innovation Casualties of Today’s Medtech Environment
This week in Pedersen's POV, our senior editor ponders a tough question about an emerging industry trend that could leave…